Literature DB >> 18602747

beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma.

Shuang Yan1, Cuiqi Zhou, Wei Zhang, Guo Zhang, Xuejian Zhao, Shangbin Yang, Yihua Wang, Ning Lu, Hongxia Zhu, Ningzhi Xu.   

Abstract

Precise roles of beta-catenin/TCF pathway involved in esophageal tumorigenesis remain elusive. Here we found STAT3 overexpression in esophageal cancer cells and tissues, and its overexpression in esophageal squamous cell carcinoma (ESCC) tissues correlated with beta-catenin cytoplasmic/nuclear accumulation. A functional TCF binding element was detected in STAT3 promoter which specifically bound to TCF4. Transfected beta-catenin induced STAT3 transcriptional activity dose-dependently, and also enhanced STAT3 mRNA and protein levels. These inductions were specifically abolished by dominant-negative TCF4. These results suggest that STAT3 is a target of beta-catenin/TCF pathway and might participate in esophageal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602747     DOI: 10.1016/j.canlet.2008.05.035

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  49 in total

Review 1.  Wnt/beta-catenin signaling in glioma.

Authors:  Kailiang Zhang; Junxia Zhang; Lei Han; Peiyu Pu; Chunsheng Kang
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

2.  Dihydromyricetin Exhibits Antitumor Activity in Nasopharyngeal Cancer Cell Through Antagonizing Wnt/β-catenin Signaling.

Authors:  Ling Ye; Gendi Yin; Miaohua Jiang; Bo Tu; Zhicheng Li; Yiming Wang
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

3.  β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Authors:  Mona Anand; Raymond Lai; Pascal Gelebart
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

4.  Phenethyl isothiocyanate suppresses the metastasis of ovarian cancer associated with the inhibition of CRM1-mediated nuclear export and mTOR-STAT3 pathway.

Authors:  Wen Yu Shao; Yong Liang Yang; Huan Yan; Qian Huang; Kai Jiang Liu; Shu Zhang
Journal:  Cancer Biol Ther       Date:  2016-12-16       Impact factor: 4.742

5.  Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.

Authors:  Jun-Xia Zhang; Jing Zhang; Wei Yan; Ying-Yi Wang; Lei Han; Xiao Yue; Ning Liu; Yong-Ping You; Tao Jiang; Pei-Yu Pu; Chun-Sheng Kang
Journal:  Neuro Oncol       Date:  2013-01-07       Impact factor: 12.300

6.  Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR/STAT3 protein pathway.

Authors:  Fang Yang; Weimin Zhang; Dan Li; Qimin Zhan
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

7.  Activation of Wnt/β-catenin signaling in Muller glia protects photoreceptors in a mouse model of inherited retinal degeneration.

Authors:  Amit K Patel; Krishna Surapaneni; Hyun Yi; Rei E I Nakamura; Sapir Z Karli; Sarah Syeda; Tinthu Lee; Abigail S Hackam
Journal:  Neuropharmacology       Date:  2014-12-06       Impact factor: 5.250

8.  Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma.

Authors:  Myoung Sook Kim; Xiaofei Chang; Cynthia LeBron; Jatin K Nagpal; Juna Lee; Yiping Huang; Keishi Yamashita; Barry Trink; Edward A Ratovitski; David Sidransky
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

9.  The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.

Authors:  Bethany M Bush; Ashton T Brock; Jiayue A Deng; Ronald A Nelson; Takita Felder Sumter
Journal:  Cell Biochem Funct       Date:  2012-09-07       Impact factor: 3.685

10.  The RhoU/Wrch1 Rho GTPase gene is a common transcriptional target of both the gp130/STAT3 and Wnt-1 pathways.

Authors:  Davide Schiavone; Sarah Dewilde; Francesco Vallania; James Turkson; Ferdinando Di Cunto; Valeria Poli
Journal:  Biochem J       Date:  2009-06-26       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.